First oral advanced therapy approved for moderate-to-severe Crohn’s disease
![women taking pill from blister pack](data:image/svg+xml,%3Csvg%20xmlns=%22http://www.w3.org/2000/svg%22%20viewBox=%220%200%20100%2056%22%3E%3C/svg%3E)
Upadacitinib has been approved for use in adults with moderate-to-severe Crohn's disease in the UK, marking the first marketing authorisation globally, and will now undergo appraisal by the National Institute for Health and Care Excellence.…
Published: 9 February 2023